| FDA Office of Clinical Pharmacology Announces Availability of 2021 Annual Report | | | The U.S. Food and Drug Administration (FDA), Office of Clinical Pharmacology (OCP) announces the availability of the 2021 OCP Annual Report. OCP is a dynamic, purpose-driven organization dedicated to promoting and protecting global public health through the application of clinical pharmacology and translational medicine principles. The 2021 OCP Annual Report highlights OCP's efforts to improve public health by building and translating knowledge of drug-response into patient-centered regulatory decisions of the highest quality. In 2021, OCP addressed multiple public health issues, including advancing therapeutics against COVID-19 and for people with unmet medical needs. OCP continued to expand model-informed approaches to accelerate the development of safe and effective drugs across the entire therapeutic landscape. OCP staff conducted groundbreaking research to ensure the safety and quality of certain commonly used over-the-counter products and leveraged multiple engagement avenues to inform policy development, expand treatment options for diverse populations, and identify opportunities for further regulatory and scientific collaboration. This annual report provides stakeholders a glimpse of OCP's accomplishments during a period of rapidly evolving science and time of profound public health need in the global community. Learn more about OCP's diverse functional responsibilities, dedicated and collaborative culture, 2021 achievements, and 2022 outlook at the following link: https://go.usa.gov/xtUca. To access past OCP annual reports and learn more about the OCP organization, visit: https://go.usa.gov/xtPhZ. | | | The Office of Clinical Pharmacology (OCP) is pleased to offer the e-mail subscription service Clinical Pharmacology Corner. This is a free service from FDA to provide occasional updates from OCP regarding newly approved therapies, new regulatory and scholarly publications, upcoming events and other items of interest. Subscribe today at https://public.govdelivery.com/accounts/USFDA/subscriber/topics and select Clinical Pharmacology Corner under Drugs. We always welcome your thoughts regarding the format, content, and utility of this communication. Comments may be sent via email to ocp@fda.hhs.gov. This communication was prepared by Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA. | | | |
No comments:
Post a Comment